Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of familial adenomatous polyposis, non-muscle invasive bladder cancer, and Type 1 diabetes and rare/orphan cancers of the brain.
Biodexa Pharmaceuticals stock last closed at $3.80, up 3.26% from the previous day, and has decreased 93.82% in one year. It has underperformed other stocks in the Biotechnology industry by 0.91 percentage points. Biodexa Pharmaceuticals stock is currently +32.87% from its 52-week low of $2.86, and -96.06% from its 52-week high of $96.50.
There are currently 45.16B shares of BDRX outstanding. The market cap of BDRX is $0.00. In the last 24 hours, 28,200 BDRX shares were traded.
You need a brokerage account in order to access the NASDAQ market and buy BDRX stock.
We believe that eToro is the best brokerage. eToro gives you:
Get $10 towards your share purchase by creating an account with eToro today. This offer is only for US users.
Open eToro AccountNow that you've chosen your brokerage, it's time to fill out some personal information so you are able to buy BDRX today.
Now that you have opened your account on one of the best stock market apps, you can securely and quickly fund your account:
Watch the walkthrough below for more details transferring money into your investment account.
After you have decided on the best place to buy Biodexa Pharmaceuticals stock, it's crucial to research their stock before you invest, so you can understand the risk and upside.
WallStreetZen was built to help average investors do more in-depth fundamental analysis.
You can see all of the due diligence checks on BDRX's stock page.
Investors use many financial metrics, analyses, models, and charts to gauge BDRX's true value.
You can access additional valuation analysis on BDRX's stock here.
You can dive deeper into what analysts are forecasting on the Biodexa Pharmaceuticals stock forecast page.
Last year, BDRX revenue was $0.00. In the last 5 year, BDRX's revenue has grown by -100% per year. This was slower than the Biotechnology industry average of 29.5%.
Find out more about BDRX's earnings and revenue performance here.
In the past 12 months, insiders at BDRX have not bought or sold any shares.
Dig into more about who owns BDRX stock here.
No, Biodexa Pharmaceuticals doesn't provide an income stream by paying out dividends.
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other traders have to say.
You have two primary types of orders:
Hit the Open Trade button and eToro will execute your order.
If you require additional help with investing in stocks on eToro, watch the how to video below:
Now that you own some shares in BDRX, you'll want to keep up with your new investment.
Put BDRX on a watchlist to track the latest developments regarding your BDRX stock.
To summarize, here are the 6 steps to buy Biodexa Pharmaceuticals stock:
If you need a brokerage account, eToro is our recommended venue.
Get Started with eToro TodayIf you want to keep an eye on your investment in Biodexa Pharmaceuticals, hit the button below to create your watchlist.